✦ LIBER ✦

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

✍ Scribed by Bissler, John J; Kingswood, J Christopher; Radzikowska, Elżbieta; Zonnenberg, Bernard A; Frost, Michael; Belousova, Elena; Sauter, Matthias; Nonomura, Norio; Brakemeier, Susanne; de Vries, Petrus J; Whittemore, Vicky H; Chen, David; Sahmoud, Tarek; Shah, Gaurav; Lincy, Jeremie; Lebwohl, David; Budde, Klemens

Book ID: 120064326
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 286 KB
Volume: 381
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(12)61767-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Everolimus for Angiomyolipoma Associ

Re: Everolimus for Angiomyolipoma Associated with Tuberous Sclerosis Complex or Sporadic Lymphangioleiomyomatosis (EXIST-2): A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial

✍ Laguna, M. Pilar 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 58 KB

Commentary on: Everolimus for Angiomyoli

Commentary on: Everolimus for Angiomyolipoma Associated With Tuberous Sclerosis Complex or Sporadic Lymphangioleiomyomatosis (EXIST-2): A Multicentre, Randomised, Double-blind, Placebo-controlled Trial

✍ Black, Peter 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 48 KB

80 Everolimus in the treatment of angiom

80 Everolimus in the treatment of angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: Results from EXIST-2

✍ K. Budde; C. Kingswood; B. Zonnenberg; M. Frost; E. Belousova; M. Sauter; M. Fis 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 21 KB

Efficacy and safety of everolimus for su

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

✍ Franz, David Neal; Belousova, Elena; Sparagana, Steven; Bebin, E Martina; Frost, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 470 KB

Everolimus in Subependymal Giant Cell As

Everolimus in Subependymal Giant Cell Astrocytomas (SEGA) Associated with Tuberous Sclerosis Complex (TSC): Results of EXIST-1, a Double-Blind Placebo-controlled Phase III Trial

✍ M. Bebin; D.N. Franz; T. Sahmoud; E. Belousova; S. Sparagana; M. Frost; J. Ford; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 65 KB

The effect of everolimus on renal angiom

The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1

✍ Kingswood, J. C.; Jozwiak, S.; Belousova, E. D.; Frost, M. D.; Kuperman, R. A.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 499 KB